KRASG12D-IN-5
KRASG12D-IN-5 (Compound 241) is an orally active KRAS(G12D) inhibitor with an IC50 of 11 nM. KRASG12D-IN-5 has potent anticancer activity with no significant cytotoxicity against BxPC-3 (WT), KRAS mutation AsPC-1 (G12D) and MIAPaCa-2 cells (G12C) with CC50s of 10.37, 0.76 and 0.3 μM, respectively. KRASG12D-IN-5 can be used for cancer research, such as lung, pancreatic and colorectal cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2933935-13-6
- 分子式: C34H31F5N6O2
- 分子量:650.64
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
|
KRAS(G12D) 11 nM (IC50) |
Parmacokinetics
| Species | Dose | Route | AUClast | T1/2 | F |
|---|---|---|---|---|---|
| Mice | 2 mg/kg | i.v. | 349 ng·h/mL | 2.42 h | 17.1 % |
| Mice | 30 mg/kg | p.o. | 922 ng·h/mL | 1.44 h | 17.1 % |
化学情報
-
CAS 番号 2933935-13-6
-
分子量 650.64
-
分子式 C34H31F5N6O2
-
SMILES
OC1=CC2=C(C(C#C)=C(C=C2)F)C(C3=C(F)C4=C(C=N3)C(N5[C@H](C(F)F)[C@H]6CC[C@](C5)([H])N6)=NC(OC[C@]78C[C@@H](F)CN7CCC8)=N4)=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)